Page results
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
When Sam Ahern was born 24 years ago, she was the smallest baby our neonatal unit had ever looked after. Now an accomplished musician and fine art student, she has gone back to meet the team that helped her win her fight for life.
-
You now need a registered site administrator to access EpicCare Link UCLH for your practice or service. If your site doesn’t have a registered administrator, you may lose access to EpicCare Link UCLH.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care as 8.7 out of 10 – the top score amongst our London peers.
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
-
The video-assisted stroke triage project, developed by the UCLH stroke service in partnership London Ambulance Service (LAS) has won the HSJ Patient Safety Award for Clinical Governance & Risk Management in Patient Safety.
File results
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)
-
FOI/2022/0155 - Patient hospital bedside and electronic patient notes